Cargando…
In Silico Study of Different Thrombolytic Agents for Fibrinolysis in Acute Ischemic Stroke
Alteplase is the only FDA-approved drug for thrombolysis in acute ischemic stroke (AIS). Meanwhile, several thrombolytic drugs are deemed to be promising candidates to substitute alteplase. This paper evaluates the efficacy and safety of urokinase, ateplase, tenecteplase, and reteplase for intraveno...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10057831/ https://www.ncbi.nlm.nih.gov/pubmed/36986658 http://dx.doi.org/10.3390/pharmaceutics15030797 |